AKT1 and neoplasm: MYCN, a member of the MYC family, upregulates IFNA17 when activated in the AKT signaling pathway, thereby promoting neuroendocrine differentiation and immunosuppressive responses within the tumor microenvironment (Wen et al., 2023).